Navigation Links
Talecris Shareholders Approve Merger with Grifols During Special Meeting of Shareholders
Date:2/14/2011

RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2011 /PRNewswire/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) announced today that its shareholders voted to approve the company's proposed merger with Grifols S.A. at a special meeting of shareholders. The preliminary tabulation indicates that approximately 86 percent of the outstanding shares were voted in favor of the transaction. Closing of the transaction remains subject to resolution of the review by the Federal Trade Commission (FTC). As the acquirer, Grifols agreed to provide written notice to the FTC staff at least thirty days prior to closing the Talecris-Grifols merger and, in any event, not to close the Talecris-Grifols merger until after 11:59 p.m. on March 20, 2011.  There can be no assurance that Grifols will reach resolution with the FTC by March 20, 2011.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com


'/>"/>
SOURCE Talecris Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Talecris Biotherapeutics Announces Teleconference and Webcast Information for Special Meeting of Shareholders
2. Talecris Biotherapeutics to Report Fourth Quarter and Full Year 2010 Financial Results
3. Talecris Biotherapeutics Announces Revised Record Date and Meeting Date for Special Meeting of Shareholders
4. Talecris Biotherapeutics Announces Jury Verdict in Contract Dispute
5. Talecris Biotherapeutics GmbH Awards Winners of the 7th Annual European ALTA Research Fellowship at 2010 ERS Meeting
6. Talecris Biotherapeutics to Report Second Quarter 2010 Financial Results
7. Talecris Biotherapeutics Announces Premerger HSR Filing
8. Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
9. Talecris Names John Perkins as Executive Vice President, Global Commercial Operations
10. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
11. Talecris Added to NASDAQ Biotechnology Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)...   Pulmatrix, Inc . (NASDAQ: PULM ... therapies to address serious pulmonary diseases, today announced that ... lungs of CF patients, PUR1900, has been designated as ... Food & Drug Administration. Under the ... development of novel drugs against important pathogens, Pulmatrix will ...
(Date:1/17/2017)...  Northwell Health today announced a collaboration with ... research. As New ... Northwell Health diagnoses and treats 19,000 new cancer ... Germany -based oncology research company working ... greatly expand cancer biobanking activities within Northwell Health ...
(Date:1/17/2017)... and Hong Kong (PRWEB) , ... January 17, ... ... lifecycle management software, and NetDimensions, a global provider of learning and performance management ... agreement for the mainland China market. , “In the life sciences industry, organizations ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... laws precedential publication its decision on the appeal filed by India-based Dishman Pharmaceutical ... breach of contract against DPCL and one of its Dishman Group’s 100% wholly ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 5, 2017  SomaLogic announced today ... Life Alliance" established by iCarbonX, the ... build a "Global Digital Health Ecosystem that can ... combination of individual,s biological, behavioral and psychological data, ... between the companies, SomaLogic will provide proteomics data ...
(Date:1/3/2017)... Onitor, provider of digital health technology for ... innovative biometric data-driven program designed to aid weight loss ... 2017 Consumer Electronics Show (CES) in Las ... the World Health Organization (WHO), have identified lifestyle risks ... are overweight or obese. WHO also states that more ...
(Date:12/20/2016)... 2016   Valencell , the leading innovator ... STMicroelectronics (NYSE: STM), a global semiconductor leader serving ... today the launch of a new, highly accurate ... includes ST,s compact SensorTile turnkey multi-sensor ... sensor system. Together, SensorTile and Benchmark deliver the ...
Breaking Biology News(10 mins):